Insights · Regulation & evidence · 10 September 2026
Ambient voice technology in UK adult social care
National guidance on AI scribing now exists, it is detailed, and it was substantially rewritten this summer. It was also written for the NHS. Here is what it says, what it does not say, and the five judgements a registered manager has to make alone.
By Mike Hubbard, Founder, VERITREND LTD · Reading time 14 minutes · Written for registered managers and nominated individuals
Currency. Every source below was checked against its primary publication on 10 September 2026, then adversarially re-checked to try to break it. Publication dates, version numbers and last-updated stamps are given throughout so you can re-check them yourself rather than take this page's word for it. Most of the core documents changed during 2026; two changed within the last six weeks. Where a claim is an inference rather than something a source states, this page says so.
Part one · The documents
What actually exists now
Until 2025 there was no national position on ambient recording in health or care. There are now five documents and a supplier registry that matter, published by three different bodies, none of them together.
The picture changed sharply on 29 July 2026, when the MHRA published its first guidance on ambient voice technology and NHS England updated its own guidance to version 3 on the same day.[1],[2] CQC set out its own position on AI two months earlier, on 21 May 2026.[19] Anything you read about this subject written before August 2026 is describing a different regulatory landscape.
| Document | Published / updated | Addressed to | Status |
|---|---|---|---|
| Guidance on the use of AI-enabled ambient scribing products in health and care settings — NHS England · version 3 | 27 Apr 2025, upd. 29 Jul 2026 | CIOs and CCIOs leading AI adoption in health settings | In force |
| Ambient voice technology-enabled products — MHRA | 29 Jul 2026, upd. 31 Jul 2026 | Manufacturers, and those deploying their products | In force |
| Medical device regulation for ambient voice technology products — NHS England · PRN02607_i | 29 Jul 2026 | NHS organisations and their boards | In force |
| Using AI-enabled ambient scribing products: information governance guidance — NHS England Digital · IG professionals | upd. 4 Jun 2026 | Information governance professionals | In force |
| Ambient Voice Technology Self-Certified Supplier Registry — NHS England Digital · 28 suppliers | upd. 2 Sep 2026 | NHS procurement teams | Self-certified |
| DCB0129 / DCB0160 clinical risk management standards — NHS England · v4.2 and v3.2, 2018 | Consultation closes 11 Sep 2026 | Manufacturers and deploying organisations | Under review |
| Artificial intelligence in health and social care: CQC's role, expectations and plans — Care Quality Commission | 21 May 2026 | All registered providers, including adult social care | In force |
Part two · The line that matters
When a scribe becomes a medical device
This is the single most useful thing the MHRA published, and it is the question to put to any supplier before anything else. The test is not the technology. It is what the product claims to do.[2]
A product's intended purpose is defined by the claims in its instructions for use, labelling, and the manufacturer's promotional materials.
The MHRA works through nine worked examples. Five are not medical devices; four are. The dividing line is whether the product derives new clinical information or merely reorganises what was said.
Not a medical device
- Producing a verbatim transcript of a conversation
- Summarising a conversation for the user to review and edit
- Formatting a transcript into structured fields for confirmation
- Matching clinical codes to terms explicitly mentioned
- Drafting a letter or discharge summary from existing information
Is a medical device
- Generating insights that suggest diagnoses or treatments
- Being marketed as guiding diagnosis or improving outcomes — even if the software only summarises
- Acting autonomously without review, such as ordering tests
- Offering suggested diagnoses, even for a human to review
Two points deserve emphasis because they catch people out. First, a disclaimer does not save a product whose marketing makes clinical claims: the MHRA says manufacturers “should mitigate risk… by design first or by introducing other protection measures before considering warnings.” Example 7 in the guidance is a product that only summarises, but is marketed as improving patient outcomes — it is a medical device because of the marketing.[2]
Second, the classification is not trivial. A product that determines “the probability of a patient having a disease or condition based on an analysis of a clinical interaction” and is intended to be relied on is providing decisive information, which puts it at Class IIa and requires an approved body — not the self-declaration route available for standard Class I.[2],[26]
What this means when you are buying
You are not the manufacturer, so the registration duty is not yours. But you are choosing what to deploy in people's homes, and NHS England's parallel guidance tells deploying organisations to “pay close attention to the capabilities of their chosen AVT product and ensure it has the appropriate medical device certification, where applicable.”[3] In practice: read the supplier's marketing, not just their compliance pack, and ask them to reconcile the two.
Part three · The gap
Five things the guidance does not say about social care
The scope line reads “health and care settings in England.” The substance does not follow through. This is not a criticism of the documents — they are good documents — but a registered manager who reads them as written for her will make at least five wrong assumptions.
Gap 01 — It is addressed to the NHS, and the addressee shapes the content
The named audience is “Chief Information Officers (CIOs) and Chief Clinical Information Officers (CCIOs) leading AI adoption in health settings.”[1] The settings enumerated run from “primary, community and care home through to specialised hospital settings.”[4] Domiciliary care is not mentioned. Neither is supported living, extra care, or reablement. The word used throughout is “clinician.”
Gap 02 — The lawful basis it recommends may not be available to you
NHS England's information governance guidance recommends Article 6(1)(e) public task and Article 9(2)(h) health and care, with implied consent under the common law duty of confidentiality. It states plainly: “You do not need to ask for explicit consent under either UK GDPR or CLDC to process data for individual care.”[5]
Article 9(2)(h) is very likely available to you — it expressly covers “the provision of health or social care” by a person who “owes a duty of confidentiality under an enactment or rule of law.”[6] Article 6(1)(e) is a different matter. The ICO confirms public task is not restricted to public authorities, but the task must be “laid down in law,” and “the application of the law” must be “clear and foreseeable.”[7] A provider delivering local-authority-commissioned care under the Care Act is in a materially different position from the same provider delivering to a private client. You cannot copy NHS England's lawful basis across. You have to do the analysis, write it down, and it may differ by funding route.
Gap 03 — “Clinician review” assumes there is a clinician
Every one of these documents rests on the same load-bearing control. NHS England: adopters must “ensure users review and approve any product outputs prior to further actions.”[1] MHRA: “Users remain responsible for reviewing, validating and approving any information generated by AVT before it is relied upon for patient care.”[3] It is also what keeps a summarisation product on the safe side of the device line.
In a domiciliary visit the person present is a care worker, not a registered professional. That does not make review impossible — it makes it a design decision you have to make explicitly and record: who confirms the note, when, against what, and what happens to an unconfirmed record. The ICO's standard for meaningful human involvement is a useful benchmark here: reviewers “should have actual ‘meaningful’ influence on the decision, including the ‘authority and competence’ to go against the recommendation.”[8] A confirm button that everyone presses without reading is not a control.
Gap 04 — The supplier registry is not a procurement route for you
The Ambient Voice Technology registry held 28 suppliers as at 2 September 2026, with applications open since 3 February 2026.[9] It is worth looking at. But NHS England is explicit that it is self-certified, that “this is not a commercial framework. Procurement will be carried out by individual NHS bodies,” and that “all assurance and decision-making sits with your local NHS organisation, not NHS England.”[9],[10] There is no equivalent list for social care buyers. Nor does the DSCR Assured Solutions List offer a route: it lists solutions “assured by NHS England” that “offer the core functional capabilities social care providers need from a DSCR” — a definition an analytics or capture layer does not meet, though NHS England has not published an explicit exclusion.
Presence on the registry tells you a supplier has self-declared against NHS criteria. Absence from it tells you almost nothing about a product built for social care.
Gap 05 — The clinical safety standards apply to you — and the guidance that says otherwise is out of date
This is the one I expected to get the other way round, and it is the reason to read statute rather than guidance. DCB0129 (manufacturers) and DCB0160 (deploying organisations) are information standards published under section 250 of the Health and Social Care Act 2012. Most commentary — including NHS England's own applicability page — still describes the old test, under which scope followed public commissioning: products “developed with private funding but… subsequently deployed in a publicly commissioned care service would fall within scope,” while wholly private ones “fall outside… but NHS Digital strongly recommend that DCB 0129 and DCB 0160 are adopted.”[11]
That test no longer reflects the Act. Section 250 was substituted by section 95(2)(a) of the Health and Care Act 2022, commenced on 7 July 2025. The applicability list is now at section 250(2B), and paragraph (d) reads: “any person, other than a public body, who is required to be registered under Chapter 2 of Part 1 of the Health and Social Care Act 2008 in respect of the carrying on of a regulated activity.”[12]
The trigger is now CQC registration, not who pays. If you are a registered provider, you are in the class of persons to whom information standards apply — for your private clients as much as your council-funded ones. Anyone still sorting their caseload into in-scope and out-of-scope by funding route is applying a test that was replaced over a year ago.
Both standards themselves date from 2018 (DCB0129 v4.2, DCB0160 v3.2) and are being revised; NHS England's consultation on that revision closes on 11 September 2026, the day after this page was first published. Separately, the Data (Use and Access) Act 2025 added “a relevant IT provider” to the same list, in force from 5 February 2026, so your supplier is now capable of carrying a duty of its own.[13]
Part four · Your staff
The half of this that nobody is writing about
A pendant or phone recording a care visit is doing two things at once. It is processing a person's special category data, which every document above addresses. It is also recording an employee, continuously, in a workplace that happens to be somebody's living room, which none of them address.
The ICO's employment guidance is unambiguous and it is the sharpest constraint on the whole category:
Using audio recording, particularly where it is continuous, is considered more privacy intrusive than purely visual recording.
You should switch off by default any capability to record audio. You should only use it in exceptional circumstances, for example by a trigger switch.
Continuous audio and video recording can be highly intrusive and you are unlikely to be able to justify it in most circumstances.
Read carefully, this is a constraint on continuous and default-on capture, not on purposeful recording of a defined activity with a trigger. That distinction is the whole design brief. A device that records the visit because the carer starts it, and stops when the visit ends, is a different proposition from a device that runs all shift.
Three further points follow. Consent will not be your lawful basis for the staff-facing processing: the ICO says “consent is not usually appropriate in the employment context, due to the imbalance of power between you and your workers.”[14] A DPIA is not optional — it is required before processing likely to result in high risk, and NHS England separately assesses a DPIA as “highly likely to be a legal requirement” for ambient scribing.[5],[14] And capture start and stop times are, functionally, timing data about a worker. If you can see them, you are monitoring; decide deliberately whether that is a purpose you are declaring, and never let it become a de facto clock-in you never told anyone about.
A gap, stated precisely
As at 10 September 2026 the ICO has published no formal guidance on ambient scribes or AI note-taking in health or social care. The nearest thing is its Tech Horizons Report 2025, which is foresight rather than guidance: it describes an app that “listens to the interactions between doctor and patient, then generates a set of clinical notes,” and attaches expectations on transparency, fairness and privacy by design.[15] The AI and data protection guidance you will be pointed to instead dates from 15 March 2023 and carries a standing notice that it is under review following the Data (Use and Access) Act.[8] If someone cites “ICO guidance on AI scribes” at you, ask for the link.
Part five · The evidence
What the research actually shows, and where it was done
The headline numbers in circulation are real. They are also all from hospitals.
| Finding | Setting | Source | Date |
|---|---|---|---|
| Up to 2–3 min saved per consultation; 23.5% more direct patient interaction time; 13.4% more patients seen per A&E shift | 9 London NHS sites, 17,000+ patient encounters | GOSH DRIVE study, cited by NHS England[16] | Jan 2026 |
| Time savings are “consistent”; whether they improve care, safety or capacity “remains unclear” | Evidence synthesis; primary and acute care. Social care not included | Nuffield Trust / NIHR RSET, phase 1[17] | 4 Feb 2026 |
| 38% support rollout, 37% oppose; 21% strongly oppose vs 11% strongly support | YouGov, 4,039 UK adults | Healthwatch England[18] | 16 Jul 2026 |
| 81% want to be told and asked; 69% more comfortable given a clear accuracy-checking commitment; ~90% unaware it had been used on them | Same poll | Healthwatch England[18] | 16 Jul 2026 |
| Comfort falls from 48% for routine health checks to 28% for mental health and 23% for domestic abuse | Same poll | Healthwatch England[18] | 16 Jul 2026 |
| Any published evaluation of ambient voice technology in UK domiciliary care | — | None located | — |
The Nuffield Trust's central criticism is worth quoting because it is the one a board should put to any supplier: evaluations “stop at the point of documenting time savings” without establishing what those minutes enable.[17] Minutes saved is an output. Whether anything changed for the person receiving care is an outcome, and almost nobody has measured it.
The Healthwatch findings matter more in domiciliary care than in a clinic, and in the same direction. Support is finely balanced and skews negative in intensity. Comfort collapses precisely around the subjects that come up in someone's home — mental health, safeguarding, domestic abuse. Disabled respondents were more sceptical than the general population. A home is not a consulting room, and the visit is not a fifteen-minute appointment that ends when the person leaves. Anyone who tells you the evidence for this technology is settled for home care is describing hospital evidence and hoping you do not check the setting.
Part six · CQC
Where the regulator actually comes into it
Not where most vendors suggest — but closer than the sector generally realises. On 21 May 2026 CQC published its position on artificial intelligence, and it names note-taking directly: “writing up notes and consultations, for example in GP and outpatient settings” is listed as a current use.[19] If you have been told CQC has said nothing about this, that is no longer true.
What it says is measured, and two sentences do most of the work. CQC “do not assess or approve specific technologies.” And: “the absence or presence of AI does not predict a specific rating.”[19] There is no tick for adopting it and no mark against you for not.
What CQC does set out is eleven expectations of any provider using AI. Six of them are procurement and governance questions you should be able to answer on the day you go live: AI to support, not to replace — “AI can enhance, but not replace human decision making”; human oversight — outputs “continuously monitored and evaluated”; transparency and choice — people have “appropriate information to make informed decisions about their care, including the role of AI in care pathways”; a DPIA; accountability — “clear mechanisms for addressing issues or harm caused by AI”; and procurement “in line with relevant regulatory standards.” The others cover safety, security, fairness, training and governance.[19]
CQC's separate guidance on surveillance in care services is worth reading alongside it, with a caveat: it covers “CCTV, cameras and microphones,” it recommends taking legal advice, and it says you “will need to tell everyone it affects.”[22] But it was last updated on 12 August 2025, it does not address people's own homes, and it does not address recording by staff. It was written for a care home lounge, not a domiciliary visit.
Underneath all of it sits the obligation that has not changed: Regulation 17(2)(c) requires you to “maintain securely an accurate, complete and contemporaneous record in respect of each service user.”[23] Note the first word — in a system built on capturing and processing audio, “securely” is doing as much work as “accurate.” How the record was produced is your business; whether it is right, complete and safely held is the regulator's.
Two pieces of timing are worth holding. The single assessment framework — 34 quality statements, six evidence categories, numerical scoring — remains the live framework being used to assess adult social care providers as at September 2026. A draft sector-specific adult social care framework was published in March 2026, replacing the quality statements with a smaller set of key lines of enquiry, removing scoring, and reintroducing rating characteristics; CQC has confirmed it “will remove scoring from our assessment approach” and that future judgements “will be made holistically using the professional judgement of our inspection teams, informed by evidence and with reference to the rating characteristics and supporting guidance.”[20] Pilots are running from June to October 2026, with final evaluation in November.[21] The five key questions and four rating levels survive. CQC has not published an implementation date; end of 2026 is a widely repeated inference from a November evaluation, not a commitment, and you should not plan procurement around it.
The practical consequence for a technology decision: do not buy anything whose value proposition is tied to the 34 quality statements or to a numerical score. Both are on their way out. The things that will still be true in 2027 are Regulation 17, the fundamental standards, and an assessment method that asks what difference the care made to the person — which is a question about the record's substance, not its production method.
Separately: the Data Security and Protection Toolkit is where most providers' actual accountability for this will sit. The 2025-26 edition (version 8) is aligned to the Cyber Assessment Framework version 3.4.[24] Check the current edition and deadline directly — this one moves.
Part seven · Practical
Twelve questions to put to a supplier
Forward this section. It is the part that does work.
- 01
Is the product registered with the MHRA as a medical device? If not, show me your written intended-purpose statement and explain which of the MHRA's nine examples you consider yourself to match.
- 02
Do any of your marketing materials describe diagnosis, prediction, risk scoring, triage or deterioration? If they do, your product may be a device regardless of what the software does — that is Example 7.
- 03
Are you on the AVT Self-Certified Supplier Registry? If yes, I understand that is self-declared, not assured. What did you self-declare against?
- 04
Have you completed DCB0129 as a manufacturer, and will you support my DCB0160? I am CQC-registered, so information standards under section 250 reach me — and since February 2026 they can reach you too.
- 05
Have you completed a DTAC on the form issued 24 February 2026? The previous version was withdrawn from use on 6 April 2026.[25]
- 06
Where is audio processed and stored, and under which jurisdiction? Name the sub-processors.
- 07
When is raw audio deleted, and can I set that period? NHS England's position is that once a summary is signed off as accurate, “the original recording and transcript could be deleted.”[5]
- 08
Will any of my data be used to train your models? Get the answer in the contract, not the sales call.
- 09
Am I the controller? Show me the data processing agreement and the instructions it records.
- 10
How does a care worker correct an error before the record is confirmed, and is the correction auditable? Ask to watch someone do it.
- 11
What happens when the device is capturing and someone present has not consented — a neighbour, a district nurse, a family member in the next room?
- 12
Can start and stop times be exported as timing data, and who can see them? If the answer is yes and you had not thought about it, you have just built a monitoring system.
Before you pilot anything
- 1
Complete a DPIA. It covers both the people you support and your workforce. These are different risks and both belong in the document.
- 2
Write down your lawful basis, and check whether it differs by funding route. Article 9(2)(h) is likely straightforward. Article 6 is the one to think about.
- 3
Consult your staff before you decide, not after. Publish a monitoring position that says what is captured, what is not, and what you will and will not look at.
- 4
Update your privacy notice, and tell people at the door. NHS England's standard is that individuals “must be told at the beginning of a session.” In someone's home that is a conversation, every time, not a poster.
- 5
Decide who confirms the record and how you will know they read it. Then audit that, not the transcription accuracy.
- 6
Agree how someone declines, how that is recorded, and how the visit proceeds normally when they do.
- 7
Re-check the sources. Three of the four changed this year. Put a date in the diary.
Sources
- [1]
Guidance on the use of AI-enabled ambient scribing products in health and care settings
NHS England, version 3. Published 27 April 2025, last updated 29 July 2026.
england.nhs.uk/long-read/guidance-on-the-use-of-ai-enabled-ambient-scribing-products-in-health-and-care-settings/↩ back to text - [2]
Ambient voice technology-enabled products
MHRA. Published 29 July 2026, updated 31 July 2026.
gov.uk/government/publications/ambient-voice-technology-enabled-products/ambient-voice-technology-enabled-products↩ back to text - [3]
Medical device regulation for ambient voice technology products
NHS England, PRN02607_i. Published 29 July 2026.
england.nhs.uk/long-read/medical-device-regulation-for-ambient-voice-technology-products/↩ back to text - [4]
AI-enabled ambient scribing products in health and care settings
NHS England, executive overview, version 1. Published 27 April 2025.
england.nhs.uk/long-read/ai-enabled-ambient-scribing-products-in-health-and-care-settings/↩ back to text - [5]
Using AI-enabled ambient scribing products in health and care settings: guidance for IG professionals
NHS England Digital. Last updated 4 June 2026.
digital.nhs.uk/data-and-information/information-governance/guidance/using-ai-enabled-ambient-scribing-products-in-health-and-care-settings/guidance-for-ig-professionals↩ back to text - [6]
Special category data: what are the conditions for processing?
ICO. Last updated 18 December 2023.
ico.org.uk/for-organisations/uk-gdpr-guidance-and-resources/lawful-basis/special-category-data/what-are-the-conditions-for-processing/↩ back to text - [7]
- [8]
Guidance on AI and data protection
ICO. Updated 15 March 2023; under review following the Data (Use and Access) Act.
ico.org.uk/for-organisations/uk-gdpr-guidance-and-resources/artificial-intelligence/guidance-on-ai-and-data-protection/↩ back to text - [9]
Ambient Voice Technology Self-Certified Supplier Registry
NHS England Digital. Last updated 2 September 2026; 28 suppliers listed; applications reopened 3 February 2026.
digital.nhs.uk/services/ambient-scribing/ambient-voice-technology-self-certified-supplier-registry↩ back to text - [10]
Adopting ambient scribing products in health and care settings
NHS England Digital. Source of “This is not a commercial framework.”
digital.nhs.uk/services/ambient-scribing↩ back to text - [11]
Applicability of DCB0129 and DCB0160: step-by-step guidance
NHS England Digital. Note: this page still describes the pre-July-2025 section 250 test and should be read against the Act itself, source 12.
digital.nhs.uk/services/clinical-safety/applicability-of-dcb-0129-and-dcb-0160/step-by-step-guidance↩ back to text - [12]
Health and Social Care Act 2012, section 250
As substituted by the Health and Care Act 2022 s.95(2)(a), commenced 7 July 2025 (SI 2025/807). Applicability list now at s.250(2B).
legislation.gov.uk/ukpga/2012/7/section/250↩ back to text - [13]
National review of clinical risk management standards DCB0129 and DCB0160
NHS England. Consultation opened 29 June 2026, closes 11 September 2026. Current versions DCB0129 v4.2 and DCB0160 v3.2, both 7 June 2018.
england.nhs.uk/long-read/national-review-of-clinical-risk-management-standardsdcb0129-and-dcb0160-supporting-information/↩ back to text - [14]
Employment practices and data protection: monitoring workers
ICO. Quotations from the sub-page on specific methods of monitoring.
ico.org.uk/for-organisations/uk-gdpr-guidance-and-resources/employment/monitoring-workers/↩ back to text - [15]
Tech Horizons Report 2025: digital diagnostics, therapeutics and healthcare infrastructure
ICO. Foresight research, not statutory guidance.
ico.org.uk/about-the-ico/research-reports-impact-and-evaluation/research-and-reports/technology-and-innovation/tech-horizons-and-ico-tech-futures/tech-horizons-report-2025/↩ back to text - [16]
NHS backs AI notetaking to free up more face-to-face care
NHS England. Published 15 January 2026, updated 16 January 2026. Figures from the GOSH DRIVE study.
england.nhs.uk/2026/01/nhs-backs-ai-notetaking-free-up-more-face-to-face-care/↩ back to text - [17]
Ambient voice technology in health care: what's the evidence so far?
Shand and Morris, Nuffield Trust / NIHR RSET. Published 4 February 2026.
nuffieldtrust.org.uk/news-item/ambient-voice-technology-in-health-care-what-s-the-evidence-so-far↩ back to text - [18]
What does the public think about AI scribe use in healthcare?
Healthwatch England. Published 16 July 2026. YouGov poll of 4,039 UK adults, fieldwork 16–27 April 2026.
healthwatch.co.uk/blog/2026-07-16/what-does-public-think-about-ai-scribe-use-healthcare↩ back to text - [19]
Artificial intelligence in health and social care: CQC's role, expectations and plans
Care Quality Commission. Page last updated 21 May 2026.
cqc.org.uk/about-us/transparency/artificial-intelligence-health-social-care-cqcs-role-expectations-plans↩ back to text - [20]
Our initial response to our public consultation: Better regulation, better care
Care Quality Commission. Published 25 March 2026.
cqc.org.uk/about-us/how-we-involve-you/consultations/initial-response-public-consultation-better-regulation-better-care↩ back to text - [21]
Piloting, testing and evaluation of our new assessment method
Care Quality Commission. Published 4 June 2026.
cqc.org.uk/about-us/improving-how-we-work/0626-update↩ back to text - [22]
Using surveillance in your care service
Care Quality Commission. Page last updated 12 August 2025.
cqc.org.uk/guidance-providers/all-services/using-surveillance-your-care-service↩ back to text - [23]
The Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, regulation 17
Good governance. Record-keeping duty at regulation 17(2)(c).
legislation.gov.uk/uksi/2014/2936/regulation/17↩ back to text - [24]
Data Security and Protection Toolkit 2025-26 (version 8)
NHS England. Published 18 September 2025; aligned to Cyber Assessment Framework v3.4. Check the current edition and deadline directly.
dsptoolkit.nhs.uk↩ back to text - [25]
Digital Technology Assessment Criteria (DTAC): guidance for buyers and suppliers
NHS England Transformation Directorate. Updated form issued 24 February 2026; previous version withdrawn from 6 April 2026.
transform.england.nhs.uk/key-tools-and-info/digital-technology-assessment-criteria-dtac/↩ back to text - [26]
Regulating medical devices in the UK
MHRA / GOV.UK. Class I self-declaration and UKCA marking; registration required for all classes.
gov.uk/guidance/regulating-medical-devices-in-the-uk↩ back to text
A note on currency. This page was compiled on 10 September 2026 against primary sources only, and then deliberately attacked: a second pass tried to falsify every claim in it, and four survived only in weakened form. Two were wrong and are corrected above — this page originally repeated the widely-quoted public-funding test for DCB0129/0160, which the Health and Care Act 2022 replaced in July 2025, and it originally stated that CQC had published nothing on AI. Most of the core documents changed during 2026 and two changed within six weeks of writing. NHS England itself is subject to the Health Bill 2026-27, which would transfer its functions to the Department of Health and Social Care; the bill had not received Royal Assent at the time of writing and no statement has been published on the continuity of its guidance. Treat every date above as a thing to re-check, not a thing to rely on indefinitely.
Disclosure and scope. I am the founder of Veritrend, which builds an ambient-audio and trend-analysis platform for domiciliary care. That is a commercial interest and you should read this page knowing it. It is written to be useful whether or not you ever speak to us — the twelve questions in Part seven are ones we expect to be asked, and answer.
This is not legal advice, and it is not a substitute for your own DPIA, your own lawful basis assessment, or advice from your data protection officer. Veritrend surfaces patterns in everyday wellbeing signals for a care team to review. It does not predict, diagnose, triage or score clinical risk.
VERITREND LTD · Company No. 17432849 · Shrewsbury · veritrend.ai